Monopar Therapeutics Income Statement

Income Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating items
Research & Development 0.28M0.94M1.77M1.97M
Selling, General & Administrative 0.91M1.17M1.56M2.36M
Other Operating Expenses 14.50M
Operating Expenses 1.19M16.60M3.33M4.32M
Operating Income -1.19M-16.60M-3.33M-4.32M
EBIT -1.19M-16.60M-3.33M-4.32M
Net income details
EBT -1.19M-16.55M-3.30M-4.32M
Profit After Tax -1.19M-16.55M-3.23M-4.22M
Income from Continuing Operations -1.19M-16.55M-3.30M-4.32M
Consolidated Net Income -1.19M-16.55M-3.30M-4.32M
Income towards Parent Company -1.19M-16.55M-3.30M-4.32M
Net Income towards Common Stockholders -1.19M-16.55M-3.30M-4.32M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 1.86M1.86M1.86M2.08M2.29M2.52M2.57M2.97M6.11M
EBITDA -1.19M-16.55M-3.23M-4.23M